Most Read News

For the first half of FY2024-25, the company's PAT increased to ₹63.07 crore, compared to ₹59.62 crore during the same period in the previous fiscal year.

Total revenue from operations rose by 10.3% to ₹2,326 crore, up from ₹2,109 crore in Q2 FY24.

Here are some of the stocks that may see significant price movement today: ONGC, Hindalco, NMDC, Britannia Industries, etc.

Brent crude prices dropped 1 cent to $71.82 per barrel. West Texas Intermediate crude futures for the United States were up 3 cents at $68.07 a barrel.

The inspection covered Active Pharmaceutical Ingredients (APIs) and Finished Dosages (FDs) for oncology and non-oncology segments, underscoring the plant’s adherence to high manufacturing standards.

Consolidated revenue for the quarter ended September 30, 2024, stood at ₹3,364 crore, an 18.6% decline from the ₹4,059.45 crore recorded in the same quarter last year.

After hitting 105.70 on Monday for the first time since July 3, the U.S. dollar index, which compares the currency to six rivals, including the euro, increased 0.07%

Asian markets traded mixed in early Tuesday session as investors remained cautious.

EBITDA reached ₹716 crore for the quarter, marking a 49.5% rise compared to ₹479 crore in Q2 2023.

The company's IPO, open from November 5 to November 7, was oversubscribed 3.2 times, receiving bids for 1,23,99,75,500 shares compared to the 38,70,64,594 shares on offer.